AZN ASTRAZENECA-ADR

Ownership history in CX Institutional  ·  5 quarters on record

This page tracks every 13F SEC filing in which CX Institutional reported a position in ASTRAZENECA-ADR (AZN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2022 Q2)
Avg. % of fund
0.0%
First filed
2021 Q3
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 34 0% 0.00% $3K $151.86
2025 Q2 REDUCED 34 -22 -39.3% 0.00% $2K $137.36
2025 Q1 REDUCED 56 -1,004 -94.7% 0.00% $4K $144.48
2022 Q2 ADDED 1,060 +106 +11.1% 0.01% $70K $121.88
2021 Q3 INITIATED 954 0.00% $57K $108.99
% of Fund (quarterly)    AZN price (monthly, adj. close)
← Back to CX Institutional Holdings